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Objective
To compare the performance of 4 sets of criteria for clini-
cal response evaluation in JIA patients.
Methods
An observational study of a non-selected cohort of JIA
patients in the out-patient clinic was conducted. Four sets
of criteria: DAS, DAS28, CDAI and SDAI were evaluated
and compared with the ACR-Ped-30 and the clinician
judgment of response (CJR) (100 mm-VAS) as the gold
standard to evaluate clinical response in JIA patients. Per-
formance was assessed by the receiver operating character-
istic (ROC) curve analysis and other statistics for
diagnostic tests.
Results
50 JIA patients (female/male ratio: 1.2:1; mean age at
diagnosis: 6.4 ± 3.3 years; mean disease duration: 5.3 ±
2.7 years) were evaluated. The area under the ROC curve
(AUC) with 95% confidence interval (95%CI), the likeli-
hood ratio (LR) with 95%CI, the sensitivity, specificity,
positive predictive value (PPV) and negative predictive
value (NPV) were: 0.842 (0.691–0.994); 6.48 (1.03–
40.75); 80.9; 87.5; 97.1; and 46.6; respectively for the CJR
in comparison with the ACR-Ped-30 as gold standard; and
of 0.700 (0.532–0.868); 2.00 (1.05–3.80); 80.0; 60.0;
82.3 56.2; respectively for the DAS28; 0.752 (0.599–
0.906); 2.89 (1.23–6.83); 77.1; 73.3; 87.1 57.8; respec-
tively for the SDAI; and 0.705 (0.542–0.868); 2.23 (1.06–
4.68); 74.2; 66.6 83.8; 52.6; respectively for the CDAI,
when compared with the CJR. The performance of the
four sets of criteria in comparison with the ACR-Ped-30
was poor.
Conclusion
In the daily clinical practice the DAS 28, SDAI and CDAI
can be used for the evaluation of clinical response in JIA
patients.
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